GERALDA VILUS: Open Payments
NPI 1407201627 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$150 in 8 payments from 4 companies in 2025. Trend: 2023 $408 · 2024 $329 · 2025 $150
Food & beverage: $150
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $42 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $17 |
Products named: UZEDY, INVEGA SUSTENNA, INGREZZA, VIVITROL, AUSTEDO XR.
Industry payments across NJ — which companies pay providers there.
